Pages that link to "Q41116012"

The following pages link to B7-mediated costimulation and the immune response (Q41116012):

Displaying 45 items.

• Structure and evolution of the extended B7 family (Q28198042) (← links)
• Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. (Q33381618) (← links)
• Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses? (Q33536297) (← links)
• On costimulatory signals and T cell tolerance: relevance for transplantation immunity. (Q33541431) (← links)
• Immunological self/nonself discrimination: integration of self vs nonself during cognate T cell interactions with antigen-presenting cells. (Q33664142) (← links)
• Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells (Q33821284) (← links)
• Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation (Q33915352) (← links)
• Dendritic cells and immunotherapy for malignant disease (Q34216506) (← links)
• Highly efficient, in-vivo Fas-mediated apoptosis of B-cell lymphoma by hexameric CTLA4-FasL. (Q34306584) (← links)
• Biological treatment in acute myelogenous leukaemia: how should T-cell targeting immunotherapy be combined with intensive chemotherapy? (Q34452706) (← links)
• Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma (Q34576803) (← links)
• Mechanisms of the Graft‐versus‐Leukemia Reaction (Q34742492) (← links)
• Targeted immunotherapy of cancer: development of antibody-induced cellular immunity. (Q35084986) (← links)
• Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells (Q35638775) (← links)
• Reflections on CD8 T-cell activation and memory (Q35794629) (← links)
• Cancer vaccine development: on the way to break immune tolerance to malignant cells. (Q35879344) (← links)
• Somatic cell engineering and the immunotherapy of leukemias and lymphomas (Q35909334) (← links)
• Cancer vaccines: preclinical studies and novel strategies (Q36543800) (← links)
• Hodgkin's lymphoma: molecular targets and novel treatment strategies (Q36572545) (← links)
• Altered maturation of peripheral blood dendritic cells in patients with breast cancer. (Q36671247) (← links)
• Validation of analytical methods in compliance with good manufacturing practice: a practical approach (Q37152649) (← links)
• Plasmodium falciparum exposure in utero, maternal age and parity influence the innate activation of foetal antigen presenting cells. (Q37428342) (← links)
• Novel antibodies against follicular non-Hodgkin’s lymphoma (Q37887147) (← links)
• Immunization against small ruminant lentiviruses (Q38126773) (← links)
• Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma (Q38219408) (← links)
• Discordant Expression of Ii and HLA-DR in Thyrocytes: A Possible Pathogenetic Factor in Hashimoto's Thyroiditis (Q38456013) (← links)
• CD86 molecule is a specific marker for canine monocyte-derived dendritic cells. (Q38552928) (← links)
• Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma (Q39690697) (← links)
• B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro (Q40169401) (← links)
• Distinct effects of CD86-mediated costimulation on resting versus activated human CD4+ T cells. (Q40369722) (← links)
• Growth suppression and immunogenicity enhancement of Hep-2 or primary laryngeal cancer cells by adenovirus-mediated co-transfer of human wild-type p53, granulocyte-macrophage colony-stimulating factor and B7-1 genes (Q40727606) (← links)
• Cellular origin and pathophysiology of chronic lymphocytic leukemia (Q41488705) (← links)
• Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo (Q42244141) (← links)
• CD80 antigen expression as a predictor of ex vivo chemosensitivity in chronic lymphocytic leukemia (Q43935084) (← links)
• B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity (Q45868892) (← links)
• Polymorphism of CTLA-4 gene for major depression in the Korean population (Q47608740) (← links)
• Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy (Q47677806) (← links)
• Defective expression and modulation of B7-2/CD86 on B cells in B cell chronic lymphocytic leukemia (Q47831959) (← links)
• [Mechanisms of tumor escape from immunologic response]. (Q52535965) (← links)
• Regulation of CD80/B7-1 and CD86/B7-2 molecule expression in human primary acute myeloid leukemia and their role in allogenic immune recognition (Q56907971) (← links)
• An array of immunotherapeutic strategies for B-cell lymphomas (Q57556559) (← links)
• Multidimensional scaling analysis identifies pathological and prognostically relevant profiles of circulating T-cells in chronic lymphocytic leukemia (Q57807709) (← links)
• Influence of CD40 ligation on survival and apoptosis of B-CLL cells in vitro (Q73668263) (← links)
• The use of combination vaccinia vaccines and dual-gene vaccinia vaccines to enhance antigen-specific T-cell immunity via T-cell costimulation (Q74586068) (← links)
• Cancer vaccines (Q77057632) (← links)